BROOKE MCARTHUR: Open Payments
NPI 1396218079 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,806 in 141 payments from 17 companies in 2025. Trend: 2023 $2,450 · 2024 $2,363 · 2025 $2,806
Food & beverage: $2,706Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 26 | $620 |
| ABBVIE INC. | 24 | $356 |
| Janssen Biotech, Inc. | 13 | $319 |
| GENZYME CORPORATION | 12 | $300 |
| Novartis Pharmaceuticals Corporation | 11 | $240 |
| UCB, Inc. | 16 | $223 |
| Lilly USA, LLC | 8 | $185 |
| Incyte Corporation | 5 | $113 |
| PFIZER INC. | 4 | $100 |
| Galderma Laboratories, L.P. | 4 | $84 |
Products named: DUPIXENT, TREMFYA, COSENTYX, Bimzelx, SKYRIZI, RINVOQ, OPZELURA, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
